Logo

Lynx Inks Gene-Expression Collaboration with Ludwig Cancer Institute

Jul 18, 2002

NEW YORK, July 18 - Lynx Therapeutics today said it will collaborate with the Ludwig Institute for Cancer Research to study cancer gene expression.

 

The LICR will pay Lynx to apply its MPSS tool to uncover differentially expressed genes in cancer samples.

 

Lynx is already engaged in a similar collaboration with the National Cancer Institute.

 

Click here for more information.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.